Top Markets
Coin of the day
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Ранг среди акций #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Цена акции
$24.37
Рыночная капитализация
$1.30B
Изменение (1 день)
-7.16%
Изменение (1 год)
-
Страна
US
Торговля Seaport Therapeutics, Inc. Common Stock (SPTX)

Категория

Коэффициент P/B для Seaport Therapeutics, Inc. Common Stock (SPTX)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Seaport Therapeutics, Inc. Common Stock, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Seaport Therapeutics, Inc. Common Stock с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH